SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012933
Filing Date
2018-05-10
Accepted
2018-05-10 16:03:18
Documents
59
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 SPERO THERAPEUTICS, INC. Q1 2018 10-Q spro-10q_20180331.htm 10-Q 1813282
2 EX-31.1 spro-ex311_11.htm EX-31.1 18285
3 EX-31.2 spro-ex312_10.htm EX-31.2 18481
4 EX-32.1 spro-ex321_9.htm EX-32.1 9815
5 EX-32.2 spro-ex322_8.htm EX-32.2 9832
  Complete submission text file 0001564590-18-012933.txt   6092097

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT spro-20180331.xml EX-101.INS 1140699
7 XBRL TAXONOMY EXTENSION SCHEMA spro-20180331.xsd EX-101.SCH 53866
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE spro-20180331_cal.xml EX-101.CAL 45231
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE spro-20180331_def.xml EX-101.DEF 203863
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20180331_lab.xml EX-101.LAB 369551
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20180331_pre.xml EX-101.PRE 302265
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 18822405
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences